Examining Scientific, Technological & Business Trends To Advance Protein & Antibody Therapeutics

Country: Germany

City: Berlin

Abstr. due: 02.01.2015

Dates: 02.02.15 — 03.02.15

Organizing comittee e-mail: steve@globalengage.co.uk

Organizers: Global Engage

 

 

Global Engage is pleased to announce the Biologics Congress 2015 which will be held on February 2-3 in Berlin, Germany.  The conference is part of our successful Drug Discovery series which includes events on synthetic biology, precision medicine, digital pathology, digital PCR and the human microbiome.

The Biologics market is evolving with the development of new products and therapies and is expected to hit $200 billion in the next few years.  With growing commercial potential, good economic returns and lower attrition rates when compared to small molecule drugs and entry barriers on the manufacturing side reducing all the time, more and more companies are entering the expanding field.

Attracting industry & academic experts working in all areas of protein and antibody research this two day interactive meeting will provide you the opportunity to take home cutting edge strategies, case study examples, developments and methods to allow you to further your research, keep abreast of your competitors and the latest technology / solution advancements in the area.

This will be achieved through a vibrant exhibition room full of technology providers showcasing their technologies and other solutions, networking breaks allowing interaction with your peers, poster presentation sessions, expert led case study presentations and incisive Q&A panel discussions from a 40 strong speaker faculty examining topics on four separate tracks covering:-
Day 1 Stream 1 -     Antibody Based Therapeutics
Day 1 Stream 2 -     Protein Expression, Purification, & Characterization
Day 2 Stream 1 -     i    Antibody-Drug Conjugates
    ii   Antibodies for Cancer Immunotherapy
Day 2 Stream 2 -     Protein Biotherapeutics

Conference Synopsis:

Day 1 Track 1
Antibody Based Therapeutics

    Antibody discovery & optimization
        Bispecific antibodies
        Monoclonal antibodies
        Recombinant antibodies
    Overcoming safety and risks
    Antibody mixtures


Day 1 Stream 2
Protein Expression, Purification, & Characterisation

    Examining different expression systems / technologies
    Strategies to improve expression, purification, increase yields and enhance protein development
    Difficult proteins
    Characterization processes
    Cell line development


Day 2 Stream 1
Antibody-Drug Conjugates

    Antibody-drug conjugates – development, potential & challenges
        Optimising ADC stability & potency
        Optimizing payloads & linkers
        Site specific ADCs
        ADC design
        Clinical updates

Antibodies for Cancer Immunotherapy

    T cell therapy
    Chimeric antigen receptors (CARS)
    Immune checkpoint blockade


Day 2 Stream 2
Protein Biotherapeutics

    Overcoming immunogenicity and aggregation issues
    Alternative scaffolds
    Half life extension
    Fusion proteins
    Protein stability

 

Conference Web-Site: http://www.globalengage.co.uk/biologics/agenda.html